Table 5 Univariate analysis of the influencing factors of atorvastatin’s lipid-lowering efficacy.
Characteristic | LDL-C ≥ 1.8 mmol/L, n = 60 | LDL-C < 1.8 mmol/L, n = 67 | χ2/t | P value |
|---|---|---|---|---|
Male, n(%) | 34(56.7) | 45(67.2) | 1.484 | 0.223 |
Age, Years (mean ± SD) | 63.28 ± 14.17 | 64.13 ± 10.94 | -0.376 | 0.708 |
BMI, kg m−2 (mean ± SD) | 24.82 ± 3.52 | 23.94 ± 2.33 | 1.630 | 0.106 |
Hypertension, n(%) | 34(56.7) | 34(50.7) | 0.446 | 0.504 |
Diabetes mellitus, n (%) | 17(28.3) | 20(29.9) | 0.035 | 0.851 |
Tobacco use history, n (%) | 20(33.3) | 31(46.3) | 2.204 | 0.138 |
Alcohol consumption patterns, n (%) | 14(23.3) | 24(35.8) | 2.354 | 0.125 |
Nighttime sleep deprivation, n (%) | 35(58.3) | 16(23.9) | 15.635 | < 0.001 |
Additive model | 10.165 | 0.006 | ||
GG, n (%) | 14(23.3) | 34(50.7) | ||
GT, n (%) | 29(48.3) | 20(29.9) | ||
TT, n (%) | 17(28.3) | 13(19.4) | ||
Dominant model | 1399 | 0.237 | ||
TT, n (%) | 17(28.3) | 13(19.4) | ||
GG་GT, n (%) | 43(71.7) | 54(80.6) | ||
Recessive model | 10.117 | 0.001 | ||
TT་GT, n (%) | 46(76.7) | 33(49.3) | ||
GG, n (%) | 14(23.3) | 34(50.7) |
